Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Gliosarcoma × Immunotherapy × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Histiocytosis 1 Head and Neck Neoplasms 1 Glioblastoma 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Brain Neoplasms 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Temozolomide 52 Bevacizumab 33 Radiotherapy 26 Radiation 12 Erlotinib Hydrochloride 12 Radiotherapy, Intensity-Modulated 8 Radiotherapy, Conformal 8 Irinotecan 6 Vorinostat 5 Sorafenib 5 Sirolimus 5 temsirolimus 4 Magnetic Resonance Spectroscopy 4 Immunoglobulin G 4 Disulfides 4 Carmustine 4 veliparib 3 plerixafor 3 carmustine, poliferprosan 20 drug combination 3 Radiosurgery 3 Everolimus 3 Dasatinib 3 Bortezomib 3 vandetanib 2 tandutinib 2 sargramostim 2 poly ICLC 2 pembrolizumab 2 pazopanib 2 ferric pyrophosphate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡